...
首页> 外文期刊>The Journal of Neuroscience: The Official Journal of the Society for Neuroscience >Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner
【24h】

Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner

机译:通过FGF受体2,不是FGF受体1,通过激活ERK1 / 2-MAPK来调节髓鞘厚度,其以AKT - 独立的方式促进MTORC1活性

获取原文
获取原文并翻译 | 示例

摘要

FGF signaling has emerged as a significant "late-stage" regulator of myelin thickness in the CNS, independent of oligodendrocyte differentiation. Therefore, it is critically important to identify the specific FGF receptor type and its downstream signaling molecules in oligodendrocytes to obtain better insights into the regulatory mechanisms of myelin growth. Here, we show that FGF receptor type 2 (FGFR2) is highly enriched at the paranodal loops of myelin. Conditional ablation of this receptor-type, but not FGF receptor type 1 (FGFR1), resulted in attenuation of myelin growth, expression of major myelin genes, key transcription factor Myrf and extracellular signal-regulated protein kinase 1 and 2 (ERK1/2) activity. This was rescued by upregulating ERK1/2 activity in these mice, strongly suggesting that ERK1/2 are key transducers of FGFR2 signals for myelin growth. However, given that the PI3K/Akt/mechanistic target of rapamycin (mTOR) pathway is also known to regulate myelin thickness, we examined FGFR2-deficient mice for the expression of key signaling molecules in this pathway. A significant downregulation of p-mTOR, p-Raptor, and p-S6RP was observed, which was restored to normal by elevating ERK1/2 activity in these mice. Similar downregulation of these molecules was observed in ERK1/2 knock-out mice. Interestingly, since p-Akt levels remained largely unchanged in these mice, it suggests a mechanism of mTORC1 activation by ERK1/2 in an Akt-independent manner in oligodendrocytes. Taken together, these data support a model in which FGFs, possibly from axons, activate FGFR2 in the oligodendrocyte/myelin compartment to increase ERK1/2 activation, which ultimately targets Myrf, as well as converges with the PI3K/Akt/mTOR pathway at the level of mTORC1, working together to drive the growth of the myelin sheath, thus increasing myelin thickness.
机译:FGF信号传导在CNS中作为髓鞘厚度的重要“晚期”调节器,与少突胶质细胞分化无关。因此,鉴定少突胶质细胞中的特异性FGF受体类型及其下游信号分子至关重要,以获得更好地了解髓鞘生长的调节机制。在这里,我们表明FGF受体2(FGFR2)高度富集髓鞘的剖腹环。这种受体型但不是FGF受体1(FGFR1)的条件消融导致髓鞘生长,主要髓鞘基因的表达,关键转录因子MyRF和细胞外信号调节蛋白激酶1和2(ERK1 / 2)的表达活动。这通过上调这些小鼠的ERK1 / 2活性来拯救,强烈表明ERK1 / 2是FGFR2信号的关键换能器,用于髓鞘生长。然而,鉴于雷帕霉素(MTOR)途径的PI3K / AKT /机械靶靶向调节髓鞘厚度,我们检查了FGFR2缺陷小鼠,用于表达该途径中的关键信号分子。观察到P-MTOR,P-RAPTOR和P-S6RP的显着下调,通过在这些小鼠中升高ERK1 / 2活性来恢复至正常。在ERK1 / 2敲除小鼠中观察到这些分子的类似下调。有趣的是,由于P-Akt水平在这些小鼠中保持大部分不变,因此在少突胶质细胞中,ERK1 / 2在互相依赖于AKT的方式的MTORC1活化机制。总之,这些数据支持哪种模型,其中FGFS可能来自轴突,激活少突胶质细胞/髓鞘中的FGFR2,以增加ERK1 / 2激活,最终靶向MYRF,以及用PI3K / AKT / MTOR途径收敛于MTORC1水平,共同推动髓鞘的生长,从而增加髓鞘厚度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号